LH | Laboratory Corporation of America Holdings Stock Overview

(Stock Exchange: NYSE)

Day's Range	247.99 - 250.81
52 Week Range	191.97 - 258.59
Beta	1.15
Implied Volatility	25.73%
IV Rank	36.20%
Day's Volume	320,021
Average Volume	550,225
Shares Outstanding	83,639,300
Market Cap	20,897,279,105
Sector	Healthcare
Industry	Medical - Diagnostics & Research
IPO Date	1990-03-29

Valuation
Profitability
Growth
Health
P/E Ratio	28.23
Forward P/E Ratio	11.44
EPS	8.85
1YR Price Target	260.00
Dividend Yield	1.16%
Dividend Per Share	2.89
Dividend ExDate	2022-11-16
Dividend PayDate	2022-12-09
Employees	67,000
Country	USA
Website	LH

Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.

LH's peers: CRL, ICLR, IQV, DGX, WAT, UHS, HUM, HOLX, MEDP, MTD, RVTY

*Chart delayed

Analyzing fundamentals for LH we got that it has average fundamentals where Valuation is considered to be fairly valued, Profitability is very poor, Growth is good and Health is passable. For more detailed analysis please see LH Fundamentals page.

Watching at LH technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on LH Technicals page.